| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 01/15/2009 | US20090014693 Selenium Containing Electrically Conductive Polymers and Method of Making Electrically Conductive Polymers |
| 01/15/2009 | DE112007000587T5 Verfahren zur Herstellung einer kondensierten Ringverbindung A process for producing a fused ring compound |
| 01/15/2009 | CA2690756A1 Novel compounds as cannabinoid receptor ligands |
| 01/14/2009 | EP2014663A1 Thieno-pyrimidyl amines as modulators of EP2 receptors |
| 01/14/2009 | EP2014662A1 Indolyl alkyl thieno-pyrimidyl amines as modulators of EP2 receptors |
| 01/14/2009 | EP2013206A1 Pharmaceutical compounds |
| 01/14/2009 | EP1463728B1 Fused cyclic modulators of nuclear hormone receptor function |
| 01/14/2009 | CN101346386A Process for the preparation of S-(+)-clopidogrel by optical resolution |
| 01/14/2009 | CN101346385A New compounds |
| 01/14/2009 | CN101346380A Pyrimidine derivatives for the treatment of abnormal cell growth |
| 01/14/2009 | CN101343280A Thiophene macrocyclic compound and preparation method for its derivant |
| 01/14/2009 | CN101343279A Preparation method for di-thiophene-[2, 3-b; 3í», 2í»-d] thiophene |
| 01/14/2009 | CN101343278A Preparation method for hydrogenated pyridine derivant and its salt |
| 01/13/2009 | US7476748 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast |
| 01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
| 01/13/2009 | US7476677 Substituted thieno- and thiazolo- [2,3-d]pyrimidines and [2,3-c]pyridines as inhibitors of Tie2 |
| 01/13/2009 | US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
| 01/13/2009 | US7476662 Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 01/13/2009 | CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase |
| 01/08/2009 | WO2009004106A1 Porous biotin carrier, and associated production methods and uses |
| 01/08/2009 | US20090012070 Pesticidal heterocycles |
| 01/08/2009 | US20090011025 Biotin-Amino Acid Conjugate Useful as a Hydrogelator and Hydrogel Prepared Therefrom |
| 01/08/2009 | US20090009061 Composition for Conductive Materials Comprising Crosslinkable Arylamine Compounds and Use Thereof in Electronic Devices and Electronic Equipment |
| 01/08/2009 | US20090008609 dehalogenation and hydrolysis to form a water soluble polythiophene monomer; PEDOT electroconductive polymers |
| 01/08/2009 | CA2692145A1 Antiviral compounds |
| 01/07/2009 | EP2010545A2 A process for the preparation of polymorph form i of (s)-(+)-methyl-alpha-(2-chlorophenyl)-6,7-dihydro-thieno-[3,2-c]pyridine-5(4h)-acetate hydrogen sulfate |
| 01/07/2009 | EP2010544A1 Process for preparing dorzolamide |
| 01/07/2009 | EP2010532A1 Tryclic nitrogen containing compounds and their use as antibacterials |
| 01/07/2009 | EP2010531A1 Spirocyclic cyclohexane derivative with analgesic properties |
| 01/07/2009 | EP1680481A4 New compound capable of being used in organic layer of organic light emitting device |
| 01/07/2009 | EP1562589B1 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 01/07/2009 | EP1218361B1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
| 01/07/2009 | CN101341154A Thienopyridine derivatives as modulators of metabotropic glutamate receptors |
| 01/07/2009 | CN101341153A New compounds |
| 01/07/2009 | CN101341152A New compounds |
| 01/07/2009 | CN100448876C Heterocyclocarboxamide derivatives |
| 01/06/2009 | US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 01/06/2009 | US7473691 Pyrazole compounds useful as protein kinase inhibitors |
| 01/01/2009 | US20090005375 Acetyl coenzyme a carboxylase inhibitors |
| 01/01/2009 | US20090005366 Deuterium-enriched olanzapine |
| 01/01/2009 | US20090001357 Novel Condensed Polycyclic Aromatic Compound and Use Thereof |
| 12/31/2008 | WO2009001214A2 Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists |
| 12/31/2008 | WO2009001128A1 1,2-cycl0hexane dicarboxamides as cathepsin inhibitors |
| 12/31/2008 | WO2009001017A2 Marking reagents bearing diazo and nitro functions, methods for the synthesis of such reagents and methods for detecting biological molecules |
| 12/31/2008 | WO2008128072A3 Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders |
| 12/31/2008 | WO2008117269A3 Heterotri cyciii c compounds as serotonergic and/or dopaminergic agents and uses thereof |
| 12/31/2008 | EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides |
| 12/31/2008 | EP2007789A2 Hcv/hiv inhibitors and their uses |
| 12/31/2008 | EP1817000B1 Thienopyrimidines as cooling agents |
| 12/31/2008 | EP1778713B1 Method for labelling and purifying nucleic acids of interest present in a biological sample to be treated in a single reaction vessel |
| 12/31/2008 | EP1648905B1 Thienopyridine and furopyridine kinase inhibitors |
| 12/31/2008 | CN101336244A 9-membered heterobicyclic compounds as inhibitors of protein kinases |
| 12/31/2008 | CN101333223A Method for preparing clopidogrel and salts thereof |
| 12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 12/30/2008 | US7470797 Nuclear hormone receptor modulator; anticarcinogenic agent; 3-(4-Cyano-3-trifluoromethylphenylcarbamoyl containing 3-carboxy-14-dimethyl-5-oxa-7-oxybicyclo(2.2.2) heptane compound |
| 12/30/2008 | US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions |
| 12/30/2008 | US7470707 Crystalline monohydrate clopidogrel naphthalenedisulfonate and process of preparation |
| 12/30/2008 | US7470705 e.g. Cis-4-[acety1-(3,5-bis-trifluoromethyl-benzyl)-amino]-2-ethyl-6-methoxy-3,4-dihydro-2H- [1,5]naphthyridine-1-carboxylic acid isopropyl ester; cholesterol ester transfer protein (CETP) inhibitors; increasing plasma HDL- cholesterol, decreasing plasma LDL- cholesterol; atherosclerosis |
| 12/30/2008 | US7470701 e.g. 3-(4-fluorophenyl)-N-{5-[2-(methylamino)pyrimidin-4-yl]thien-2-yl}propanamide; PKB/Akt kinase inhibitor; anticarcinogenic agent; carcinoma, cancer metastases, squamous cell carcinoma, esophageal squamous cell carcinoma, oral carcinoma, cutaneous T cell lymphoma, Hodgkin's lymphoma |
| 12/30/2008 | US7470694 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase |
| 12/30/2008 | US7470691 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 12/25/2008 | US20080319004 Deuterium-enriched clopidogrel |
| 12/25/2008 | US20080318997 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 12/25/2008 | US20080318959 using 3-amino-5-ethyl-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide |
| 12/25/2008 | US20080318338 Drug screening using a high affinity form of Heat Shock Protein-90 (HSP90) that has a 17-allylamino-geldanamycin (17-AAG) binding affinity |
| 12/24/2008 | WO2008157563A2 Deuterium-enriched clopidogrel |
| 12/24/2008 | WO2008157562A2 Deuterium-enriched olanzapine |
| 12/24/2008 | WO2008155468A1 Activators and therapeutic applications thereof |
| 12/24/2008 | WO2008155441A1 Activators and therapeutic applications thereof |
| 12/24/2008 | WO2008155132A1 Spiro [piperidine-4, 4' -thieno [3, 2-c] pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
| 12/24/2008 | WO2008155017A1 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular diseases |
| 12/24/2008 | WO2008131119A3 Composition and method for cancer treatment and prevention |
| 12/24/2008 | EP2006291A1 Fused ring compound and method for producing same, polymer, organic thin film containing those, and organic thin film device and organic thin film transistor comprising such organic thin film |
| 12/24/2008 | EP2004656A1 Thienopyrimidines having mnkl /mnk2 inhibiting activity for pharmaceutical compositions |
| 12/24/2008 | EP2004647A1 Hiv inhibiting 3,4-dihydro-imidazoý4,5-b¨pyridin-5-ones |
| 12/24/2008 | EP1697427B1 Metallocene compounds |
| 12/24/2008 | EP1620425B1 Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists |
| 12/24/2008 | CN101331125A N-(5-membered aromatic ring)-amido anti-viral compounds |
| 12/24/2008 | CN101328186A Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |
| 12/24/2008 | CN101328185A Method for synthesizing biotin from 1,3-dibenzyl-4-alkoxy biotin intermediate |
| 12/24/2008 | CA2691227A1 Activators and therapeutic applications thereof |
| 12/24/2008 | CA2690545A1 Substituted bicyclic heteroaryl compounds and their use |
| 12/24/2008 | CA2690249A1 Spiro [piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
| 12/23/2008 | US7468371 Tricyclic pyrazole kinase inhibitors |
| 12/22/2008 | CA2593407A1 Improved processes for the synthesis of olanzapine |
| 12/18/2008 | WO2008152159A2 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators |
| 12/18/2008 | WO2008151430A1 Novel processes to form-i of olanzapine |
| 12/18/2008 | WO2008080056A3 Pyridazinones and furan-containing compounds |
| 12/18/2008 | WO2008031888A3 Condensed pyrimidinones active on glutamatergic receptors |
| 12/18/2008 | US20080312433 Novel process to Form-I of olanzapine |
| 12/18/2008 | US20080312431 Responsive Luminescent Lanthanide Complexes |
| 12/18/2008 | US20080312312 For treating prostate cancer; (6S,6aR,10aS)-2-Hydroxy-6-(4-hydroxy-phenyl)-6,6a,7,8,10,10a-hexahydro-benzo[c]chromen-9-one; testicular cancer, cardiovascular diseases, neurodegenerative disorders, urinary incontinence, central nervous system disorders, gastrointestinal tract disorders, osteoporosis |
| 12/18/2008 | US20080312185 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES |
| 12/18/2008 | US20080311609 Novel Molecular Probes |
| 12/18/2008 | DE102007027800A1 Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung Substituted bicyclic heteroaryl compounds and their use |
| 12/17/2008 | EP2003488A2 Second order nonlinear optical chromophores, Polymers containing the same, and electro-optic devices therefrom |
| 12/17/2008 | EP2003136A1 Process for producing high-purity prasugrel and acid addition salt thereof |
| 12/17/2008 | EP2002834A1 Aryl and hetaryl amides as modulators of EP2 receptors |